| Level I | Good quality evidence |
Systematic review of RCTs with consistent findings High quality individual RCT |
| Level II |
Limited quality patient orientated evidence |
Systematic review of lower quality studies or studies with inconsistent findings Low quality clinical trial Cohort studies Case-control studies |
| Level III | Other |
Consensus guidelines, extrapolations from bench research, usual practice, opinion, disease-oriented evidence (intermediate or physiologic outcomes only), or case series |
[3] Gentamicin, parenteral: National Department of Health: Affordable Medicines, EDP-Adult Hospital level. Medicine Review: Gentamicin for uncomplicated UTI, November 2019. http://www.health.gov.za/
Gentamicin, parenteral: Goodlet KJ, Benhalima FZ, Nailor MD. A Systematic Review of Single-Dose Aminoglycoside Therapy for Urinary Tract Infection: Is It Time To Resurrect an Old Strategy? Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e02165-18. https://www.ncbi.nlm.nih.gov/pubmed/30397061
Gentamicin, parenteral: National Department of Health: Affordable Medicines, EDP-PHC/Adult Hospital level. Summary Review: Antimicrobials for uncomplicated UTI in adults, October 2020. http://www.health.gov.za/
Gentamicin, parenteral: National Department of Health: Affordable Medicines, EDP-PHC/Adult Hospital level. Summary Review: Gentamicin dosing for uncomplicated UTI in adults, October 2020. http://www.health.gov.za/
Gentamicin, parenteral: Stamey, T. A., D. E. Govani and J. M. Palmer. 1965. The localization and treatment of urinary tract infections: the role of bactericidal urine levels as opposed to serum levels. Medicine (Baltimore). 1965 Jan;44:1-36. https://pubmed.ncbi.nlm.nih.gov/14264351/
Gentamicin, parenteral: Sandoz Canada Inc. Product monograph: PrGentamicin Injection USP, 29 August 2017. https://www.sandoz.ca/sites/www.sandoz.ca/files/Gentamicin%20Inj%20Product%20Monograph.pdf